RNA解析/トランスクリプトミクスの世界市場レポート 2025年

RNA解析/トランスクリプトミクスの市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR17.1％で165億4,000万米ドルに成長します。予測期間の成長は、シングルセルRNAシーケンス用途、臨床診断におけるRNA解析の統合、RNAベースの治療とワクチン、バイオインフォマティクスとデータ解析ツール、バイオマーカーの発見と検証に起因しています。予測期間における主な動向には、空間トランスクリプトミクスとin situ RNA解析、ロングリードRNAシーケンス技術、RNA編集と修飾解析、RNAデータ解析におけるAIの統合、希少疾患のためのRNA治療薬、がん検出のためのRNAベースのリキッドバイオプシーなどがあります。

RNA分析／トランスクリプトミクス市場の成長は、個別化医療に対する需要の高まりが牽引すると予想されます。個別化医療とは、患者一人ひとりの特性に合わせた治療を行うことです。RNA-Seq技術は、個別化医療の実践とプロセスの実施に伴う膨大な臨床作業量を管理するのに適しています。個別化医療連合（PMC）は2022年10月に、複数の種類のがん、遺伝的希少疾患、慢性疾患や感染症など様々な症状に対して、7万5,000品目を超える遺伝子検査製品と300品目を超える個別化医薬品が利用可能になると報告しています。このような個別化医薬品に対する需要の急増は、RNA分析市場の成長を促進する重要な要因です。

慢性疾患の有病率の増加は、今後のRNA解析/トランスクリプトミクス市場の拡大を促進すると予想されます。慢性疾患とは、日常生活に支障をきたし、継続的な医療ケアを必要とする1年以上続く状態を指します。慢性疾患の研究においてRNA解析とトランスクリプトミクスを使用することで、疾患メカニズムの理解が深まり、より良い診断につながり、より的を絞った個別化治療介入の開発が容易になります。例えば、2022年9月、スイスに本部を置く国連の専門機関である世界保健機関（WHO）は、世界的に毎年4,100万人が亡くなっており、非感染性疾患（NCDs）または慢性疾患による死亡は全体の74％を占めると報告しました。このうち、心血管疾患による死亡者は1,790万人、がんによる死亡者は930万人、慢性呼吸器疾患による死亡者は410万人、糖尿病による死亡者は200万人です。このように、慢性疾患の罹患率の上昇が、RNA解析/トランスクリプトミクス市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のRNA解析/トランスクリプトミクス市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のRNA解析/トランスクリプトミクス市場：成長率分析
• 世界のRNA解析/トランスクリプトミクス市場の実績：規模と成長、2019～2024年
• 世界のRNA解析/トランスクリプトミクス市場の予測：規模と成長、2024～2029年、2034年
• 世界のRNA解析/トランスクリプトミクス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のRNA解析/トランスクリプトミクス市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 試薬・消耗品
• 機器
• ソフトウェア
• 世界のRNA解析/トランスクリプトミクス市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• マイクロアレイ
• シーケンシング
• ポリメラーゼ連鎖反応RNA干渉
• 世界のRNA解析/トランスクリプトミクス市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 臨床診断
• 創薬
• 毒性ゲノミクス
• 比較トランスクリプトミクス
• RNA干渉
• 世界のRNA解析/トランスクリプトミクス市場：試薬・消耗品のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ヌクレオチド
• 酵素
• バッファーと溶液
• サンプル調製キット
• シーケンシングキット
• 世界のRNA解析/トランスクリプトミクス市場：機器のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• シーケンサー
• リアルタイムPCR装置
• マイクロアレイ
• 電気泳動システム
• ロボットリキッドハンドラー
• 世界のRNA解析/トランスクリプトミクス市場：ソフトウェアのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• データ分析ソフトウェア
• バイオインフォマティクスツール
• 統計解析ソフトウェア
• 可視化ソフトウェア
• データベース管理システム

第7章 地域別・国別分析

• 世界のRNA解析/トランスクリプトミクス市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のRNA解析/トランスクリプトミクス市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• RNA解析/トランスクリプトミクス市場：競合情勢
• RNA解析/トランスクリプトミクス市場：企業プロファイル
  • Affymetrix Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• QIAGEN N.V.
• F. Hoffmann-La Roche Ltd.
• Sigma-Aldrich Corporation
• Thermo Fisher Scientific Inc.
• Fluidigm Corporation
• Promega Corporation
• bioMerieux S.A.
• CD Genomics Inc.
• Eurofins Scientific SE
• Merck KGaA
• Pacific Biosciences of California Inc.
• Danaher Corporation
• Genewiz Inc.
• Oxford Nanopore Technologies Ltd.
• BGI Group

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• RNA解析/トランスクリプトミクス市場2029：新たな機会を提供する国
• RNA解析/トランスクリプトミクス市場2029：新たな機会を提供するセグメント
• RNA解析/トランスクリプトミクス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Transcriptomics, also known as RNA analysis, is the study of the transcriptome under specific circumstances, environmental conditions, or within specific cells using high-throughput methods.

The main product categories in the RNA analysis/transcriptomics market include reagents/consumables, instruments, and software. These products find applications in various fields, such as clinical diagnostics, drug discovery, toxicogenomics, comparative transcriptomics, and RNA interference. The major technologies involved in RNA analysis/transcriptomics are microarrays, sequencing, polymerase chain reaction, and RNA interference. In clinical diagnostics, RNA analysis is employed to detect different RNA species, pathogen RNA, splice variants, and other elements crucial for disease diagnosis.

The RNA analysis/ transcriptomics market research report is one of a series of new reports from The Business Research Company that provides RNA analysis/ transcriptomics market statistics, including RNA analysis/ transcriptomics industry global market size, regional shares, competitors with a RNA analysis/ transcriptomics market share, detailed RNA analysis/ transcriptomics market segments, market trends and opportunities, and any further data you may need to thrive in the RNA analysis/ transcriptomics industry. This RNA analysis/ transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The RNA analysis/ transcriptomics market size has grown rapidly in recent years. It will grow from $7.72 billion in 2024 to $8.8 billion in 2025 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to cancer research and precision medicine, drug discovery and development, infectious disease diagnostics, personalized medicine, academic and government funding, growing applications in agriculture.

The RNA analysis/ transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $16.54 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to single-cell rna sequencing applications, integration of rna analysis in clinical diagnostics, rna-basedTherapies and vaccines, bioinformatics and data analysis tools, biomarker discovery and validation. Major trends in the forecast period include spatial transcriptomics and in situ rna analysis, long-read rna sequencing technologies, rna editing and modification analysis, integration of ai in rna data analysis, rna therapeutics for rare diseases, rna-based liquid biopsy for cancer detection.

The growth of the RNA analysis/transcriptomics market is anticipated to be driven by the increasing demand for personalized medicine. Personalized medicine involves tailoring medical treatment to the unique characteristics of each patient. The RNA-Seq technology is well-suited to manage the substantial clinical workload associated with implementing personalized clinical care practices and processes. The Personalized Medicine Coalition (PMC) reported in October 2022 that there will be over 75,000 genetic testing products and 300 personalized medicines available for various conditions such as multiple types of cancer, genetic rare diseases, and chronic and infectious diseases. This surge in demand for personalized medicines is a key factor propelling the growth of the RNA analysis market.

The growing prevalence of chronic diseases is expected to drive the expansion of the RNA analysis/transcriptomics market in the future. Chronic diseases are defined as conditions lasting a year or longer that hinder daily activities and necessitate ongoing medical care. The use of RNA analysis and transcriptomics in chronic disease research enhances understanding of disease mechanisms, leads to better diagnostics, and facilitates the development of more targeted and personalized therapeutic interventions. For instance, in September 2022, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths each year, accounting for 74% of deaths caused by non-communicable diseases (NCDs) or chronic diseases, occur globally. Among these, there were 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the rising incidence of chronic diseases is propelling the growth of the RNA analysis/transcriptomics market.

An emerging trend in the RNA analysis/transcriptomics market is the focus on technological advancements and innovations in RNA analysis. Next-generation sequencing (NGS) and RNA interference (RNAi) are among the technologies contributing to improved precision and accuracy in analyzing transcriptional activity. Illumina's development of Next-generation sequencing, for example, has proven successful in fragmenting DNA/RNA, sequencing libraries, and reassembling them, enhancing genomic sequence analysis.

Major companies in the RNA analysis/transcriptomics market are increasingly emphasizing the introduction of innovative portfolios to gain a competitive advantage. Twist Bioscience Corporation, in May 2023, launched a comprehensive RNA sequencing tools portfolio, including specific target enrichment capabilities for RNA and whole transcriptome sequencing. The portfolio comprises products such as the Twist RNA Exome, Twist RNA Library Prep Kit, and Twist Ribosomal RNA (rRNA) and Hemoglobin (Globin) Depletion Kit, offering complete workflows for analyzing mRNA protein coding sequences, custom targets, and total RNA.

Strategic partnerships and collaborations are a significant focus for major companies in the RNA analysis/transcriptomics market. These partnerships often involve integrating expertise in RNA library preparation kits, combining the knowledge and resources of different organizations. For instance, Singular Genomics Systems Inc. collaborated with Lexogen in January 2022 to demonstrate the compatibility of the G4 sequencing platform with Lexogen's products for RNA research. This partnership aims to provide customers with a seamless integration of the G4 into existing Next-Generation Sequencing (NGS) workflows.

Major companies operating in the RNA analysis/ transcriptomics market include Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., Fluidigm Corporation, Promega Corporation, bioMerieux S.A., CD Genomics Inc., Eurofins Scientific SE, Merck KGaA, Pacific Biosciences of California Inc., Danaher Corporation, Genewiz Inc., Oxford Nanopore Technologies Ltd., BGI Group, Genotypic Technology Pvt. Ltd., MedGenome Labs Pvt. Ltd., Xcelris Labs Ltd., Ocimum Biosolutions Ltd., Strand Life Sciences Pvt. Ltd., SciGenom Labs Pvt. Ltd., Oncocyte Corporation, Tempus Labs Inc., ArcherDX Inc., HTG Molecular Diagnostics Inc.

North America was the largest region in the RNA analysis/transcriptomics market in 2024. This region is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA analysis/ transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the RNA analysis/ transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The RNA analysis/ transcriptomics market includes revenues earned by entities by providing services such as Whole-Genome Sequencing, Whole-Exome Sequencing, Targeted Sequencing, Microarray Analysis, Sanger Sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

RNA Analysis/ Transcriptomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rna analysis/ transcriptomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rna analysis/ transcriptomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rna analysis/ transcriptomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Reagents/Consumables; Instruments; Software

2) By Technology; Microarrays; Sequencing; Polymerase Chain Reaction RNA Interference

• 3) By Application: Clinical Diagnostics; Drug Discovery; Toxicogenomics; Comparative Transcriptomics; RNA Interference
• Subsegments:
• 1) By Reagents/Consumables: Nucleotides; Enzymes; Buffers and Solutions; Sample Preparation Kits; Sequencing Kits
• 2) By Instruments: Sequencers; Real-Time PCR Machines; Microarrays; Electrophoresis Systems; Robotic Liquid Handlers
• 3) By Software: Data Analysis Software; Bioinformatics Tools; Statistical Analysis Software; Visualization Software; Database Management Systems
• Companies Mentioned: Affymetrix Inc.; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; GE Healthcare; Illumina Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. RNA Analysis/ Transcriptomics Market Characteristics

3. RNA Analysis/ Transcriptomics Market Trends And Strategies

4. RNA Analysis/ Transcriptomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global RNA Analysis/ Transcriptomics Growth Analysis And Strategic Analysis Framework

• 5.1. Global RNA Analysis/ Transcriptomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global RNA Analysis/ Transcriptomics Market Growth Rate Analysis
• 5.4. Global RNA Analysis/ Transcriptomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global RNA Analysis/ Transcriptomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global RNA Analysis/ Transcriptomics Total Addressable Market (TAM)

6. RNA Analysis/ Transcriptomics Market Segmentation

• 6.1. Global RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents/Consumables
• Instruments
• Software
• 6.2. Global RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microarrays
• Sequencing
• Polymerase Chain Reaction RNA Interference
• 6.3. Global RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Diagnostics
• Drug Discovery
• Toxicogenomics
• Comparative Transcriptomics
• RNA Interference
• 6.4. Global RNA Analysis/ Transcriptomics Market, Sub-Segmentation Of Reagents/Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nucleotides
• Enzymes
• Buffers and Solutions
• Sample Preparation Kits
• Sequencing Kits
• 6.5. Global RNA Analysis/ Transcriptomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencers
• Real-Time PCR Machines
• Microarrays
• Electrophoresis Systems
• Robotic Liquid Handlers
• 6.6. Global RNA Analysis/ Transcriptomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis Software
• Bioinformatics Tools
• Statistical Analysis Software
• Visualization Software
• Database Management Systems

7. RNA Analysis/ Transcriptomics Market Regional And Country Analysis

• 7.1. Global RNA Analysis/ Transcriptomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global RNA Analysis/ Transcriptomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific RNA Analysis/ Transcriptomics Market

• 8.1. Asia-Pacific RNA Analysis/ Transcriptomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China RNA Analysis/ Transcriptomics Market

• 9.1. China RNA Analysis/ Transcriptomics Market Overview
• 9.2. China RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India RNA Analysis/ Transcriptomics Market

• 10.1. India RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan RNA Analysis/ Transcriptomics Market

• 11.1. Japan RNA Analysis/ Transcriptomics Market Overview
• 11.2. Japan RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia RNA Analysis/ Transcriptomics Market

• 12.1. Australia RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia RNA Analysis/ Transcriptomics Market

• 13.1. Indonesia RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea RNA Analysis/ Transcriptomics Market

• 14.1. South Korea RNA Analysis/ Transcriptomics Market Overview
• 14.2. South Korea RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe RNA Analysis/ Transcriptomics Market

• 15.1. Western Europe RNA Analysis/ Transcriptomics Market Overview
• 15.2. Western Europe RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK RNA Analysis/ Transcriptomics Market

• 16.1. UK RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany RNA Analysis/ Transcriptomics Market

• 17.1. Germany RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France RNA Analysis/ Transcriptomics Market

• 18.1. France RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy RNA Analysis/ Transcriptomics Market

• 19.1. Italy RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain RNA Analysis/ Transcriptomics Market

• 20.1. Spain RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe RNA Analysis/ Transcriptomics Market

• 21.1. Eastern Europe RNA Analysis/ Transcriptomics Market Overview
• 21.2. Eastern Europe RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia RNA Analysis/ Transcriptomics Market

• 22.1. Russia RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America RNA Analysis/ Transcriptomics Market

• 23.1. North America RNA Analysis/ Transcriptomics Market Overview
• 23.2. North America RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA RNA Analysis/ Transcriptomics Market

• 24.1. USA RNA Analysis/ Transcriptomics Market Overview
• 24.2. USA RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada RNA Analysis/ Transcriptomics Market

• 25.1. Canada RNA Analysis/ Transcriptomics Market Overview
• 25.2. Canada RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America RNA Analysis/ Transcriptomics Market

• 26.1. South America RNA Analysis/ Transcriptomics Market Overview
• 26.2. South America RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil RNA Analysis/ Transcriptomics Market

• 27.1. Brazil RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East RNA Analysis/ Transcriptomics Market

• 28.1. Middle East RNA Analysis/ Transcriptomics Market Overview
• 28.2. Middle East RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa RNA Analysis/ Transcriptomics Market

• 29.1. Africa RNA Analysis/ Transcriptomics Market Overview
• 29.2. Africa RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. RNA Analysis/ Transcriptomics Market Competitive Landscape And Company Profiles

• 30.1. RNA Analysis/ Transcriptomics Market Competitive Landscape
• 30.2. RNA Analysis/ Transcriptomics Market Company Profiles
  • 30.2.1. Affymetrix Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. RNA Analysis/ Transcriptomics Market Other Major And Innovative Companies

• 31.1. QIAGEN N.V.
• 31.2. F. Hoffmann-La Roche Ltd.
• 31.3. Sigma-Aldrich Corporation
• 31.4. Thermo Fisher Scientific Inc.
• 31.5. Fluidigm Corporation
• 31.6. Promega Corporation
• 31.7. bioMerieux S.A.
• 31.8. CD Genomics Inc.
• 31.9. Eurofins Scientific SE
• 31.10. Merck KGaA
• 31.11. Pacific Biosciences of California Inc.
• 31.12. Danaher Corporation
• 31.13. Genewiz Inc.
• 31.14. Oxford Nanopore Technologies Ltd.
• 31.15. BGI Group

32. Global RNA Analysis/ Transcriptomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The RNA Analysis/ Transcriptomics Market

34. Recent Developments In The RNA Analysis/ Transcriptomics Market

35. RNA Analysis/ Transcriptomics Market High Potential Countries, Segments and Strategies

• 35.1 RNA Analysis/ Transcriptomics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 RNA Analysis/ Transcriptomics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 RNA Analysis/ Transcriptomics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer